SZ441 (Metformin Hydrochloride and Pioglitazone Hydrochloride 500 mg / 15 mg (base))
Pill with imprint SZ441 is White, Elliptical / Oval and has been identified as Metformin hydrochloride and pioglitazone hydrochloride 500 mg / 15 mg (base). It is supplied by Sandoz Inc..
Metformin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/pioglitazone 500 mg / 15 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for SZ441
Metformin hydrochloride and pioglitazone hydrochloride
- Imprint:
- SZ441
- Strength:
- 500 mg / 15 mg (base)
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Sandoz Inc.
- National Drug Code (NDC):
- 00781-5626
More about metformin/pioglitazone
- Metformin/pioglitazone Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 6 Reviews
- Drug class: antidiabetic combinations
Consumer resources
- Metformin and pioglitazone
- Pioglitazone and Metformin Extended-Release Tablets
- Pioglitazone and Metformin Tablets
- Pioglitazone and metformin (Advanced Reading)
Other brands: ActoPlus Met, ActoPlus Met XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
